All AbMole products are for research use only, cannot be used for human consumption.
Ionomycin causes a rapid rise in cytosolic Ca2+ that is due to both a release of cytosolic Ca2+ stores and Ca2+ influx. Ionomycin also activates (2 microM) and primes (20-200 nM) the PMN oxidase. Ionomycin is shown to be an effective ionophore for Ca2+ in rat liver mitochondria. DNA and protein analysis in Ionomycin (SQ23377)-treated cultures revealed DNA fragmentation and PARP cleavage to an 85-kDa fragment typical of caspase-mediated apoptosis. Three hours after addition of ionomycin, the percentage of early apoptotic cells approximately doubles. Necrosis could be detected in ~1-5% of the Ionomycin (SQ23377) treated cells as supported by simultaneously positive fluorescein labeling and propidium iodide uptake.
Nat Commun. 2024 Oct 23;15(1):9114.
A splicing isoform of PD-1 promotes tumor progression as a potential immune checkpoint
Ionomycin purchased from AbMole
Nat Commun. 2023 Mar 23;14(1):1606.
Modular-designed engineered bacteria for precision tumor immunotherapy via spatiotemporal manipulation by magnetic field
Ionomycin purchased from AbMole
Adv Sci (Weinh). 2023 Nov 30;e2305175.
Single‐Cell Atlas of Human Ovaries Reveals The Role Of The Pyroptotic Macrophage in Ovarian Aging
Ionomycin purchased from AbMole
J Immunother Cancer. 2023 Oct;11(10):e007230.
Bladder cancer intrinsic LRFN2 drives anticancer immunotherapy resistance by attenuating CD8+ T cell infiltration and functional transition
Ionomycin purchased from AbMole
Neurochem Res. 2023 Feb;48(2):447-457.
Ca2+ Regulates Autophagy Through CaMKKβ/AMPK/mTOR Signaling Pathway in Mechanical Spinal cord Injury: An in vitro Study
Ionomycin purchased from AbMole
Exp Cell Res. 2023 Nov 15;432(2):113778.
YTHDF1 shapes “cold” tumor and inhibits CD8+ T cells infiltration and function in breast cancer
Ionomycin purchased from AbMole
Hematol Oncol. 2023 Jul 26.
Magnesium enhances the graft-versus-tumor effect of donor lymphocytic infusion on hematologic malignancies
Ionomycin purchased from AbMole
Research Square. 2023 May 5.
Breast cancer intrinsic YTHDF1 forms “cold” tumor and inhibits CD8+ T cells infiltration and function
Ionomycin purchased from AbMole
Front Immunol. 2022 May 23;13:866638.
A Novel STAT3 Gain-of-Function Mutation in Fatal Infancy-Onset Interstitial Lung Disease
Ionomycin purchased from AbMole
| Molecular Weight | 709.01 |
| Formula | C41H72O9 |
| CAS Number | 56092-81-0 |
| Solubility (25°C) | Ethanol ≥ 10 mg/mL |
| Storage | -20°C, dry, protect from light, sealed |
| Related Calcium Channel Products |
|---|
| CBD3063
CBD3063 is a selective, first-in-class, CRMP2-based peptidomimetic small molecule, which allosterically regulates Cav2.2 to achieve analgesia and pain relief without negative side effect profiles. |
| TTA-A8
TTA-A8 is a short-acting T-type calcium channel antagonist with oral activity, exhibiting an IC50 value of 31.3 nM in the FLIPR depolarization assay. |
| MONIRO-1
MONIRO-1 is a T-type and N-type calcium channel blocker with IC50 values of 34, 3.3, 1.7 and 7.2 µM against hCav2.2, hCav3.1, hCav3.2 and hCav3.3, respectively. |
| Azumolene
Azumolene (EU4093 free base), a Dantrolene analog, is a muscle relaxant. |
| Nexopamil
Nexopamil is a calcium antagonist of Ca2+ channel, 5HT2, 5HT1A, 5HT1C and dopamine D2 receptors. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
